Overview

Drug-drug Interaction Study of XZP-3621 Tablet

Status:
Not yet recruiting

Trial end date:
2023-08-02

Target enrollment:

Participant gender:

Summary

This is an open-label, single center, 2 period, one sequence study to investigate the potential drug drug interaction between itraconazole or rifampin or esomeprazole and XZP-3621 tablet.

Phase:

Phase 1

Details

Lead Sponsor:

Xuanzhu Biopharmaceutical Co., Ltd.

Treatments:

Esomeprazole
Itraconazole
Rifampin